Table 3.
DHEAS levels during the inpatient stay according to functional outcome at discharge (dichotomized modified Rankin Scale score)
| Minimum | Maximum | Mean | SD | 95 % CI | Number | |
|---|---|---|---|---|---|---|
| DHEAS day 0 | ||||||
| Favorable | <150 | 5260 | 1431 | 1077 | 1081, 1782 | 38 |
| Unfavorable | <150 | 2370 | 955 | 730 | 712, 1199 | 37 |
| DHEAS day 1 | ||||||
| Favorable | <150 | 4460 | 1132 | 989 | 802, 1462 | 37 |
| Unfavorable | <150 | 2740 | 785 | 646 | 566, 1004 | 36 |
| DHEAS day 4 | ||||||
| Favorable | <150 | 2840 | 710 | 662 | 486, 934 | 36 |
| Unfavorable | <150 | 1700 | 223 | 453 | 215, 542 | 32 |
| DHEAS day 7 | ||||||
| Favorable | <150 | 3780 | 781 | 796 | 507, 1054 | 35 |
| Unfavorable | <150 | 1110 | 282 | 343 | 156, 407 | 31 |
| DHEAS day 10 | ||||||
| Favorable | <150 | 5770 | 961 | 1202 | 542, 1380 | 34 |
| Unfavorable | <150 | 937 | 247 | 245 | 152, 342 | 28 |
| DHEAS day 14 | ||||||
| Favorable | <150 | 2560 | 634 | 602 | 405, 863 | 29 |
| Unfavorable | <150 | 1520 | 371 | 430 | 189, 553 | 24 |
Dehydroepiandrosterone-sulfate (DHEAS) levels (ng/ml) during the acute stage of disease according to dichotomized (Favorable vs Unfavorable modified Rankin Scale score) outcome at discharge. Number number of cases analyzed